PT Wirontono Baru
⚠️ High Risk
FEI: 3013264783 • Jakarta, Jabotabek • INDONESIA
FEI Number
3013264783
Location
Jakarta, Jabotabek
Country
INDONESIAAddress
Jln. Ancol Iii No 1-2, , Jakarta, Jabotabek, Indonesia
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
VETDRUGRES
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain a new animal drug (or conversion product thereof) that is unsafe within the meaning of Section 512. Product contains
LISTERIA
The article is subject to refusal of admission pursuant to Section 801(a)(3), in that the article appears to contain Listeria monocytogenes, a poisonous and deleterious substance, which may render it injurious to health.
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
HEALTH C
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.
UNSAFE COL
The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).
SALMONELLA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain Salmonella, a poisonous and deleterious substance which may render it injurious to health.
FALSE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.
COLOR LBLG
The article appears to contain an artificial coloring and it fails to bear labeling stating that fact.
TRANSFAT
The product is misbranded under Section 403(q) because the nutrition label does not provide all of the information required by 21 CFR 101.9(c); specifically, the label does not bear the amount of trans fat [21 CFR 101.9(c)(2)(ii)].
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/20/2021 | 16JGN05SHRIMP & PRAWNS | 295LISTERIA | Division of Northeast Imports (DNEI) |
| 7/2/2013 | 16XGN21SHRIMP AND PRAWNS, AQUACULTURE HARVESTED FISHERY/SEAFOOD PRODUCTS | 295LISTERIA | New York District Office (NYK-DO) |
| 9/14/2011 | 16XGT21SHRIMP AND PRAWNS, AQUACULTURE HARVESTED FISHERY/SEAFOOD PRODUCTS | 2860VETDRUGRES | Los Angeles District Office (LOS-DO) |
| 9/14/2011 | 16XGT21SHRIMP AND PRAWNS, AQUACULTURE HARVESTED FISHERY/SEAFOOD PRODUCTS | 2860VETDRUGRES | Los Angeles District Office (LOS-DO) |
| 9/14/2011 | 16XGT21SHRIMP AND PRAWNS, AQUACULTURE HARVESTED FISHERY/SEAFOOD PRODUCTS | 2860VETDRUGRES | Los Angeles District Office (LOS-DO) |
| 9/14/2011 | 16XGT21SHRIMP AND PRAWNS, AQUACULTURE HARVESTED FISHERY/SEAFOOD PRODUCTS | 2860VETDRUGRES | Los Angeles District Office (LOS-DO) |
| 9/14/2011 | 16XGT21SHRIMP AND PRAWNS, AQUACULTURE HARVESTED FISHERY/SEAFOOD PRODUCTS | 2860VETDRUGRES | Los Angeles District Office (LOS-DO) |
| 9/14/2011 | 16XGT21SHRIMP AND PRAWNS, AQUACULTURE HARVESTED FISHERY/SEAFOOD PRODUCTS | 2860VETDRUGRES | Los Angeles District Office (LOS-DO) |
| 6/1/2010 | 16JGD05SHRIMP & PRAWNS | 9SALMONELLA | New York District Office (NYK-DO) |
| 1/9/2009 | 36AGT03CANE SUGAR (SUCROSE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 1/9/2009 | 36AGT03CANE SUGAR (SUCROSE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 10/9/2008 | 36AGT03CANE SUGAR (SUCROSE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 10/9/2008 | 36AGT03CANE SUGAR (SUCROSE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 8/22/2007 | 31KGT99TEA, N.E.C. | Los Angeles District Office (LOS-DO) | |
| 8/8/2007 | 36AGT03CANE SUGAR (SUCROSE) | Los Angeles District Office (LOS-DO) | |
| 6/21/2007 | 36AGT03CANE SUGAR (SUCROSE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 5/4/2005 | 31KGT99TEA, N.E.C. | Los Angeles District Office (LOS-DO) |
Frequently Asked Questions
What is PT Wirontono Baru's FDA import refusal history?
PT Wirontono Baru (FEI: 3013264783) has 17 FDA import refusal record(s) in our database, spanning from 5/4/2005 to 12/20/2021.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. PT Wirontono Baru's FEI number is 3013264783.
What types of violations has PT Wirontono Baru received?
PT Wirontono Baru has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about PT Wirontono Baru come from?
All FDA import refusal data for PT Wirontono Baru is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.